Making 3D Printing of Human Biological Bodies Possible with Significant Ukrainian Startup


A well-known Ukrainian developer Kwambio, closely cooperating with WeFund Ventures has successfully introduced their common multifaceted project called ADAM. For those who are far from nanomedicine ideas and principles but desire to stay updated, the importance of ADAM should be associated with the phrase “since now they can literally print human bones and organs.”

Primarily, what do we know about Kwambio? It’s a Ukrainian startup located in Odessa that deals with ceramic constituents and 3D printers for medical purposes. They have already won their reputation while cooperating with such world giants as Airbus, General Electric, and NASA. This time, Kwambio has prepared a unique solution for mankind.

Reasons to Be Really Proud of ADAM

In one of the latest interviews, General Director of Kwambio, as well as CEO of ADAM startup Volodymyr Usov, has shared the opinion regarding great expectations of mankind towards this development.

“If they take into account the US, one of the most developed countries in the world, we see that around one hundred twenty-three (!) patients are registered in the waiting list for organ transplants. Over the world, this number increases to around one million people who are eager to win a chance for a normal life. Nanotechnologies such as ADAM are meant to fix this problem,” — as Usov informs.

Ukrainian startup is considered the very first opportunity to print human bones and save people’s lives. Actually, “to save people’s lives” is the target for this project to be launched at all.

Key Aspects of ADAM Startup

It was already mentioned that ADAM is defined as a multifaceted development. This means as follows:

·         They design a 3D printing technology with the goal to print biological skeletal textures;

·         By means of ADAM development, both manufacturers are intensively working on the introduction software that makes it possible to design their personal body anatomy in a virtual format consisting of MRI imagery as well as 3D scans. Such software may provide a user with quick and simple access to info about their body and, at the same time, the opportunity to print a required organ or bone for a patient directly in the hospital;

·         Moreover, the developers of this startup have additionally designed a few innovational biomaterials provided by the project, i.e. modified biopolymer and bioglass aimed to assist in printing both vessels and soft tissues. Two new bio items already underwent testing in Sweden and nowadays they are being tested in Ukrainian clinics.

Currently, an Odessa-based Kwambio manufacturer is making titanic effort to create an absolutely innovational organ and bone bioprinter that will be used in labs and even medical universities. The official representation of a prototype with the official results of pre-clinical experiments is scheduled for late 2019 while the commercial introduction of the development is planned for September 2020.

It’s also known that Techstars and Applied Medical companies are among the initiative partners to support ADAM development in the future.